Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ARSA |
| Upstream (Parents) |
|---|
| (<<) ALK → ARSA |
| (<<) BCL2A1 → ARSA |
| (<<) CALML5 → ARSA |
| (<<) CFL1 → ARSA |
| (<<) DNM1L → ARSA |
| (<<) DYNC1LI2 → ARSA |
| (<<) GNAI2 → ARSA |
| (<<) HK2 → ARSA |
| (<<) MAP3K9 → ARSA |
| (<<) MAPK13 → ARSA |
| (<<) NEUROG1 → ARSA |
| (<<) PAK1 → ARSA |
| (<<) SLC26A1 → ARSA |
| (<<) STX1A → ARSA |
| (<<) TAF9 → ARSA |
| (<<) TARS → ARSA |
| (<<) TCF4 → ARSA |
| Downstream (Children) |
|---|
| ARSA → APC2 (>>) |
| ARSA → AQP3 (>>) |
| ARSA → CEBPD (>>) |
| ARSA → CRCT1 (>>) |
| ARSA → E2F2 (>>) |
| ARSA → FER1L4 (>>) |
| ARSA → FGF1 (>>) |
| ARSA → INSR (>>) |
| ARSA → LSM1 (>>) |
| ARSA → PTGS1 (>>) |
